Results 11 to 20 of about 23,293 (223)
Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies [PDF]
Drug Design, Development and Therapy, 2012 Lindsay S Keir,1 Stephen D Marks,2 Jon Jin Kim21Academic Renal Unit, University of Bristol, Bristol; 2Department of Paediatric Nephrology, Great Ormond Street Hospital NHS Foundation Trust, London, United KingdomAbstract: Hemolytic uremic syndrome is the
Keir LS, Marks SD, Kim JJ
doaj +1 more source
Atypical hemolytic uremic syndrome [PDF]
Orphanet Journal of Rare Diseases, 2011 Hemolytic uremic syndrome (HUS) is defined by the triad of mechanical hemolytic anemia, thrombocytopenia and renal impairment. Atypical HUS (aHUS) defines non Shiga-toxin-HUS and even if some authors include secondary aHUS due to Streptococcus pneumoniae
Frémeaux-Bacchi Véronique +1 more
doaj +3 more sources
Hemolytic Uremic Syndrome [PDF]
Emerging Infectious Diseases, 1995 Mary Beers, Scott Cameron
doaj +3 more sources
Revista de Nefrología, Diálisis y Trasplante, 2014 Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy defined by thrombocytopenia, nonimmune microangiopathic hemolytic anemia, and acute renal failure. The most frequent form is associated with infections by Shiga-like toxin-producing bacteria (STEC-HUS).
Marta Lidia Monteverde
doaj +5 more sources
Hemolytic Uremic Syndrome [PDF]
Journal of the American Society of Nephrology, 2005 Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy defined by thrombocytopenia, nonimmune microangiopathic hemolytic anemia, and acute renal failure. The most frequent form is associated with infections by Shiga-like toxin-producing bacteria (STEC-HUS).
Marina, Noris, Giuseppe, Remuzzi
openaire +4 more sources
Delayed and sequencial hemolytic uremic syndrome as a complication of Gemcitabine therapy [PDF]
, 2022 Gemcitabine is a widely used drug in the treatment of diverse malignancies and its use has been approved by the US Food and Drug Administration. This drug has been associated with a rare adverse event, the Hemolytic Uremic Syndrome (HUS), characterized ...
Paulo Marcelo Gehm Hoff +4 more
core +1 more source
Brazilian Journal of Nephrology, 2020 Thrombotic microangiopathies are disorders characterized by nonimmune microangiopathic hemolytic anemia, thrombocytopenia, and multi-systemic failure.
John Fredy Nieto-Rios +7 more
doaj +2 more sources
Hemolytic uremic syndrome (HUS) – case report
Journal of Education, Health and Sport, 2020 Introduction Hemolytic uremic syndrome (HUS) is characterized by hemolytic anemia, thrombocytopenia and acute renal failure. In 90% of children, HUS most often develops after an intestinal infection caused by verotoxin-producing E. coli. The remaining 10%
Aleksandra Borkowska +5 more
doaj +1 more source
Journal of Medical Case Reports, 2022 Background Atypical hemolytic uremic syndrome, also called the nondiarrheal form of hemolytic uremic syndrome, is a rare disease characterized by the triad of thrombocytopenia, Coomb’s test-negative microangiopathic hemolytic anemia, and acute renal ...
Xin Wei +5 more
doaj +1 more source